Recursion Pharmaceuticals, Inc. (RXRX)

Recursion Pharmaceuticals Statistics

Total Valuation

RXRX has a market cap or net worth of $2.34 billion. The enterprise value is $1.85 billion.

Market Cap	2.34B
Enterprise Value	1.85B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025, after market close.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

RXRX has 402.29 million shares outstanding. The number of shares has increased by 31.92% in one year.

Current Share Class	395.07M
Shares Outstanding	402.29M
Shares Change (YoY)	+31.92%
Shares Change (QoQ)	+18.92%
Owned by Insiders (%)	4.73%
Owned by Institutions (%)	73.30%
Float	382.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	27.08
Forward PS	30.33
PB Ratio	2.23
P/TBV Ratio	4.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	31.47
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.10.

Current Ratio	3.81
Quick Ratio	3.43
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-304.71

Financial Efficiency

Return on equity (ROE) is -61.89% and return on invested capital (ROIC) is -36.13%.

Return on Equity (ROE)	-61.89%
Return on Assets (ROA)	-28.48%
Return on Invested Capital (ROIC)	-36.13%
Return on Capital Employed (ROCE)	-37.98%
Revenue Per Employee	$73,549
Profits Per Employee	-$579,576
Employee Count	800
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

Income Tax	-1.13M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.87% in the last 52 weeks. The beta is 0.84, so RXRX's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-42.87%
50-Day Moving Average	7.36
200-Day Moving Average	7.19
Relative Strength Index (RSI)	37.70
Average Volume (20 Days)	18,024,152

Short Selling Information

The latest short interest is 75.45 million, so 18.76% of the outstanding shares have been sold short.

Short Interest	75.45M
Short Previous Month	63.75M
Short % of Shares Out	18.76%
Short % of Float	19.71%
Short Ratio (days to cover)	2.75

Income Statement

In the last 12 months, RXRX had revenue of $58.84 million and -$463.66 million in losses. Loss per share was -$1.69.

Revenue	58.84M
Gross Profit	-300.82M
Operating Income	-479.00M
Pretax Income	n/a
Net Income	-463.66M
EBITDA	-442.51M
EBIT	-479.00M
Loss Per Share	-$1.69

Balance Sheet

The company has $594.35 million in cash and $108.49 million in debt, giving a net cash position of $485.86 million or $1.21 per share.

Cash & Cash Equivalents	594.35M
Total Debt	108.49M
Net Cash	485.86M
Net Cash Per Share	$1.21
Equity (Book Value)	1.03B
Book Value Per Share	2.61
Working Capital	526.80M

Cash Flow

In the last 12 months, operating cash flow was -$359.17 million and capital expenditures -$13.70 million, giving a free cash flow of -$372.87 million.

Operating Cash Flow	-359.17M
Capital Expenditures	-13.70M
Free Cash Flow	-372.87M
FCF Per Share	-$0.93

Margins

Gross Margin	n/a
Operating Margin	-814.09%
Pretax Margin	-789.93%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.92%
Shareholder Yield	n/a
Earnings Yield	-19.84%
FCF Yield	-15.95%

Analyst Forecast

The average price target for RXRX is $8.25, which is 42.00% higher than the current price. The consensus rating is "Buy".

Price Target	$8.25
Price Target Difference	42.00%
Analyst Consensus	Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RXRX has an Altman Z-Score of 1.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.1
Piotroski F-Score	3